Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
RXRX
TMDX
Add up to 3 more stocks
RXRX
Recursion Pharmaceuticals, Inc.
+1.23%
$4.12+0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$2.16B
52W Range
$2.77 - $7.18
TMDX
TransMedics Group, Inc.
+1.47%
$79.80+1.16Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$2.76B
52W Range
$60.10 - $156.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 20.67 |
| Forward P/E | N/A | 54.40 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.36 | 5.32 |
| P/S Ratio | 39.41 | 4.13 |
| P/FCF Ratio | N/A | 34.89 |
| EV/EBITDA | N/A | 26.71 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -62.0% | 58.7% |
| Operating Margin | -867.9% | 12.2% |
| Net Margin | -945.9% | 22.7% |
| ROE | -56.7% | 29.3% |
| ROA | -42.8% | 10.4% |
| ROIC | -49.8% | 5.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.03 | 6.62 |
| Quick Ratio | 5.03 | 6.07 |
| Debt/Equity | 0.07 | 1.67 |
| Interest Coverage | -358.08 | 7.88 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.